Chen Wenjun, Xiao Longfei, Guo Wenlong, Li Hailin, Chen Rong, Duan Zhongyu, Chen Qinghua, Lei Qing
College of Ethnic Medicine, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Yunnan Key Laboratory of Dai and Yi Medicines, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Front Pharmacol. 2024 Dec 9;15:1449972. doi: 10.3389/fphar.2024.1449972. eCollection 2024.
Hypertension is a common disease; however, it is more prevalent in older adults, and its prevalence is increasing in younger populations. Numerous studies have revealed that hypertension and the composition and functionality of the intestinal flora are closely correlated. The balance of the intestinal flora, intestinal barrier integrity, and metabolite content of the intestinal flora play significant roles in the occurrence and progression of hypertension. Therefore, we performed a comprehensive review of Traditional Chinese medicine (TCM) for hypertension, focusing on the role of the intestinal flora to understand the mechanism by which TCM regulates hypertension through its effects on the intestinal flora. We analyzed the findings using the terms "traditional Chinese medicine," "hypertension," "high blood pressure," "blood pressure," "intestinal flora," "intestinal barrier function," "intestinal flora metabolites," and other keywords from the China National Knowledge Infrastructure, VIP Chinese Science and Technology, Wanfang Data, PubMed, and ScienceDirect databases. We found that TCM treats hypertension by regulating the balance of the intestinal microbiota, increasing the abundance of beneficial bacteria, reducing the abundance of harmful bacteria, improving intestinal barrier function, increasing compact proteins, reducing intestinal permeability, and regulating the content of intestinal flora metabolites. The use of TCM to treat hypertension by regulating the intestinal flora is a promising therapeutic strategy. However, most studies are limited by small sample sizes and there is a lack of large-scale randomized controlled trials. In the future, multi-center controlled clinical trials are needed to verify the efficacy and safety of TCM, optimize therapeutic protocols, and establish a foundation for the standardized and personalized application of TCM in hypertension management.
高血压是一种常见疾病;然而,它在老年人中更为普遍,且在年轻人群中的患病率也在上升。众多研究表明,高血压与肠道菌群的组成和功能密切相关。肠道菌群的平衡、肠道屏障完整性以及肠道菌群的代谢产物含量在高血压的发生和发展中起着重要作用。因此,我们对中医治疗高血压进行了全面综述,重点关注肠道菌群的作用,以了解中医通过对肠道菌群的影响来调节高血压的机制。我们使用“中医”“高血压”“高血压”“血压”“肠道菌群”“肠道屏障功能”“肠道菌群代谢产物”等关键词,在中国知网、维普中文科技期刊、万方数据、PubMed和ScienceDirect数据库中分析了相关研究结果。我们发现,中医通过调节肠道微生物群的平衡、增加有益菌的丰度、降低有害菌的丰度、改善肠道屏障功能、增加紧密蛋白、降低肠道通透性以及调节肠道菌群代谢产物的含量来治疗高血压。通过调节肠道菌群来使用中医治疗高血压是一种有前景的治疗策略。然而,大多数研究受样本量小的限制,且缺乏大规模随机对照试验。未来,需要多中心对照临床试验来验证中医的疗效和安全性,优化治疗方案,并为中医在高血压管理中的标准化和个性化应用奠定基础。